Average Co-Inventor Count = 6.81
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Inspire Pharmaceuticals, Inc. (9 from 91 patents)
2. Merck Sharp + Dohme Corp. (7 from 2,405 patents)
3. Epizyme, Inc. (1 from 158 patents)
4. Inspire (1 from 1 patent)
18 patents:
1. 12116358 - Substituted indoles and methods of use thereof
2. 11230547 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
3. 10508108 - Tricyclic compounds as inhibitors of mutant IDH enzymes
4. 10442819 - Tricyclic compounds as inhibitors of mutant IDH enzymes
5. 10086000 - Tricyclic compounds as inhibitors of mutant IDH enzymes
6. 9221809 - Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
7. 9169260 - Amidopyrazole inhibitors of interleukin receptor-associated kinases
8. 8835457 - Bridged bicyclic RHO kinase inhibitor compounds, compositions and use
9. 8604205 - Cytoskeletal active rho kinase inhibitor compounds, composition and use
10. 8604218 - Cytoskeletal active rho kinase inhibitor compounds, composition and use
11. 8476295 - Bridged bicyclic RHO kinase inhibitor compounds, composition and use
12. 8410147 - Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds
13. 8299096 - Method for treating pulmonary diseases using rho kinase inhibitor compounds
14. 8207195 - Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
15. 8071779 - Cytoskeletal active rho kinase inhibitor compounds, composition and use